KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 142 filers reported holding KURA ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 1.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $984,500 | +15.0% | 93,053 | +32.9% | 0.00% | – |
| Q1 2023 | $855,990 | +511.0% | 69,991 | +520.0% | 0.00% | – |
| Q4 2022 | $140,096 | -59.9% | 11,289 | -55.8% | 0.00% | – |
| Q3 2022 | $349,000 | +3.9% | 25,519 | +39.2% | 0.00% | – |
| Q2 2022 | $336,000 | +103.6% | 18,333 | +78.4% | 0.00% | – |
| Q1 2022 | $165,000 | -70.4% | 10,276 | -74.2% | 0.00% | – |
| Q4 2021 | $558,000 | +142.6% | 39,843 | +223.9% | 0.00% | – |
| Q3 2021 | $230,000 | -45.0% | 12,300 | -38.6% | 0.00% | – |
| Q2 2021 | $418,000 | -33.3% | 20,045 | -9.6% | 0.00% | – |
| Q1 2021 | $627,000 | -79.8% | 22,181 | -76.7% | 0.00% | -100.0% |
| Q4 2020 | $3,107,000 | +9.6% | 95,121 | +2.8% | 0.00% | +100.0% |
| Q3 2020 | $2,836,000 | +544.5% | 92,535 | +189.2% | 0.00% | 0.0% |
| Q4 2019 | $440,000 | +64.2% | 31,996 | +134.8% | 0.00% | – |
| Q2 2019 | $268,000 | – | 13,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |